WordNet
- lying between two extremes in time or space or state; "going from sitting to standing without intermediate pushes with the hands"; "intermediate stages in a process"; "intermediate stops on the route"; "an intermediate range plane"
- a substance formed during a chemical process before the desired product is obtained
- of or relating to metabolism; "metabolic rate"
- undergoing metamorphosis (同)metabolous
PrepTutorEJDIC
- (程度・距離・時間などにおいて)中間の,中間にある(起こる)
- 新陳代謝の
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/12/24 10:33:55」(JST)
[Wiki en表示]
Metabolic intermediates refers to molecules which are the precursors or metabolites of biologically significant molecules.
Although these intermediates are of relatively minor direct importance to cellular function, they can play important roles in the allosteric regulation of enzymes.
Clinical significance
Some can be useful in measuring rates of metabolic processes (for example, 3,4-dihydroxyphenylacetic acid or 3-aminoisobutyrate).
Because they can represent unnatural points of entry into natural metabolic pathways, some (such as AICA ribonucleotide) are of interest to researchers in developing new therapies.
See also
Fructose and galactose metabolic intermediates
|
|
Fructose |
- Fructose-1-phosphate → DHAP/Glyceraldehyde → Glyceraldehyde 3-phosphate
|
|
Galactose |
- Galactose-1-phosphate → Glucose 1-phosphate → Glucose 6-phosphate → Fructose 6-phosphate
|
|
- Uridine diphosphate galactose
- Uridine diphosphate glucose
|
|
|
|
|
Mannose |
- Mannose-6-phosphate → Fructose 6-phosphate
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
Glycogenesis and glycogenolysis metabolic intermediates
|
|
Glucose |
- Glucose 6-phosphate
- Glucose 1-phosphate
|
|
Uridine |
- Uridine diphosphate glucose
- Uridine triphosphate
|
|
Other |
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
Pentose phosphate pathway metabolic intermediates
|
|
Oxidative |
- 6-Phosphogluconolactone
- 6-Phosphogluconate
- Ribulose 5-phosphate
- Ribose 5-phosphate
|
|
Nonoxidative |
- Xylulose 5-phosphate
- Sedoheptulose 7-phosphate
- Erythrose 4-phosphate
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
Cholesterol and steroid metabolic intermediates
|
|
Mevalonate pathway |
to HMG-CoA |
- Acetyl-CoA
- Acetoacetyl-CoA
- HMG-CoA
|
|
Ketone bodies |
- Acetone
- Acetoacetic acid
- β-Hydroxybutyric acid
|
|
to DMAPP |
- Mevalonic acid
- Phosphomevalonic acid
- 5-Diphosphomevalonic acid
- Isopentenyl pyrophosphate
- Dimethylallyl pyrophosphate
|
|
Geranyl- |
- Geranyl pyrophosphate
- Geranylgeranyl pyrophosphate
|
|
Carotenoid |
- Prephytoene diphosphate
- Phytoene
|
|
|
Non-mevalonate pathway |
- DOXP
- MEP
- CDP-ME
- CDP-MEP
- MEcPP
- HMB-PP
- IPP
- DMAPP
|
|
|
To Cholesterol |
- Farnesyl pyrophosphate
- Squalene
- 2,3-Oxidosqualene
- Lanosterol
- Lanosterol
- Lathosterol
- 7-Dehydrocholesterol
- Cholesterol
- Lanosterol
- Zymosterol
- 7-Dehydrodesmosterol
- Desmosterol
- Cholesterol
|
|
From Cholesterol
(to steroids) |
- 22R-Hydroxycholesterol
- 20α,22R-Dihydroxycholesterol
|
|
Steroid hormones |
Corticosteroids
(C21 pregnane) |
Mineralocorticoids |
- Pregnenolone
- Progesterone
- Cortodoxone
- Corticosterone
- Aldosterone
|
|
Glucocorticoids |
- Pregnenolone
- 17-Hydroxypregnenolone
- 17-Hydroxyprogesterone
- Cortisol
|
|
|
Sex steroids |
Androgens
(C19 androstane) |
- DHEA
- Androstenedione/5-Androstenediol
- Testosterone
- Dihydrotestosterone
- DHEA sulfate
- Epitestosterone
|
|
Estrogens
(C18 estrane) |
- Estetrol
- Estrone
- Estradiol
- Estriol
|
|
|
|
Nonhuman |
Phytosterols |
- Stigmasterol
- Brassicasterol
|
|
Ergosterols |
- Ergosterol
- Ergocalciferol
|
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
noco (d)/cong/tumr, sysi/epon
|
proc, drug (A10/H1/H2/H3/H5)
|
|
- Biochemical families
- carbohydrates
- alcohols
- glycoproteins
- glycosides
- lipids
- eicosanoids
- fatty acids / intermediates
- glycerides
- phospholipids
- sphingolipids
- steroids
- nucleic acids
- constituents / intermediates
- proteins
- amino acids / intermediates
- tetrapyrroles / intermediates
|
|
Amino acid metabolism metabolic intermediates
|
|
K→acetyl-CoA |
lysine→
|
- Saccharopine
- Allysine
- α-Aminoadipic acid
- α-Aminoadipate
- Glutaryl-CoA
- Glutaconyl-CoA
- Crotonyl-CoA
- β-Hydroxybutyryl-CoA
|
|
leucine→
|
- α-Ketoisocaproic acid
- Isovaleryl-CoA
- 3-Methylcrotonyl-CoA
- 3-Methylglutaconyl-CoA
- HMG-CoA
|
|
tryptophan→alanine→
|
- N'-Formylkynurenine
- Kynurenine
- Anthranilic acid
- 3-Hydroxykynurenine
- 3-Hydroxyanthranilic acid
- 2-Amino-3-carboxymuconic semialdehyde
- 2-Aminomuconic semialdehyde
- 2-Aminomuconic acid
- Glutaryl-CoA
|
|
|
G |
G→pyruvate→citrate
|
glycine→serine→
|
- glycine→creatine: Glycocyamine
- Phosphocreatine
- Creatinine
|
|
|
G→glutamate→
α-ketoglutarate
|
histidine→
|
- Urocanic acid
- Imidazol-4-one-5-propionic acid
- Formiminoglutamic acid
- Glutamate-1-semialdehyde
|
|
proline→
|
- 1-Pyrroline-5-carboxylic acid
|
|
arginine→
|
- Ornithine
- Putrescine
- Agmatine
|
|
other
|
- cysteine+glutamate→glutathione: γ-Glutamylcysteine
|
|
|
G→propionyl-CoA→
succinyl-CoA
|
valine→
|
- α-Ketoisovaleric acid
- Isobutyryl-CoA
- Methacrylyl-CoA
- 3-Hydroxyisobutyryl-CoA
- 3-Hydroxyisobutyric acid
- 2-Methyl-3-oxopropanoic acid
|
|
isoleucine→
|
- 2,3-Dihydroxy-3-methylpentanoic acid
- 2-Methylbutyryl-CoA
- Tiglyl-CoA
- 2-Methylacetoacetyl-CoA
|
|
methionine→
|
- generation of homocysteine: S-Adenosyl methionine
- S-Adenosyl-L-homocysteine
- Homocysteine
- conversion to cysteine: Cystathionine
- alpha-Ketobutyric acid+Cysteine
|
|
threonine→
|
|
|
propionyl-CoA→
|
|
|
|
G→fumarate
|
phenylalanine→tyrosine→
|
- 4-Hydroxyphenylpyruvic acid
- Homogentisic acid
- 4-Maleylacetoacetic acid
|
|
|
G→oxaloacetate
|
|
|
|
Other |
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
- Biochemical families
- carbohydrates
- alcohols
- glycoproteins
- glycosides
- lipids
- eicosanoids
- fatty acids / intermediates
- glycerides
- phospholipids
- sphingolipids
- steroids
- nucleic acids
- constituents / intermediates
- proteins
- amino acids / intermediates
- tetrapyrroles / intermediates
|
|
Nucleotide metabolic intermediates
|
|
Purine metabolism |
Anabolism |
R5P→IMP: |
- R5P
- PRPP
- PRA
- GAR
- FGAR
- FGAM
- AIR
- CAIR
- SAICAR
- AICAR
- FAICAR
|
|
IMP→AMP: |
|
|
IMP→GMP: |
|
|
|
Catabolism |
- Hypoxanthine
- Xanthine
- Uric acid
- 5-Hydroxyisourate
|
|
|
Pyrimidine metabolism |
Anabolism |
- Carbamoyl phosphate
- Carbamoyl aspartic acid
- 4,5-Dihydroorotic acid
- Orotic acid
- Orotidine 5'-monophosphate
- Uridine monophosphate
|
|
Catabolism |
uracil: |
- Dihydrouracil
- 3-Ureidopropionic acid
- β-Alanine
|
|
thymine: |
- Dihydrothymine
- β-Ureidoisobutyric acid
- 3-Aminoisobutyric acid
|
|
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
- Biochemical families
- carbohydrates
- alcohols
- glycoproteins
- glycosides
- lipids
- eicosanoids
- fatty acids / intermediates
- glycerides
- phospholipids
- sphingolipids
- steroids
- nucleic acids
- constituents / intermediates
- proteins
- amino acids / intermediates
- tetrapyrroles / intermediates
|
|
Neurotransmitter metabolic intermediates
|
|
catecholamines |
Anabolism
(tyrosine→epinephrine) |
- Tyrosine → Levodopa → Dopamine → Norepinephrine → Epinephrine
|
|
Catabolism/
metabolites |
dopamine: |
- DOPAL
- DOPAC
- MOPET
- Hydroxytyrosol
- 3-Methoxytyramine
- Homovanillic acid
|
|
norepinephrine: |
- 3,4-Dihydroxymandelic acid
- Normetanephrine
- Vanillylmandelic acid
- 3-Methoxy-4-hydroxyphenylglycol
- Dihydroxyphenylethylene glycol
|
|
epinephrine: |
|
|
|
|
tryptophan→serotonin |
anabolism: |
|
|
catabolism: |
- 5-Hydroxyindoleacetic acid
|
|
|
serotonin→melatonin |
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
Heme metabolic intermediates
|
|
Porphyrin biosynthesis |
early mitochondrial: |
|
|
cytosolic: |
- Porphobilinogen
- Hydroxymethylbilane
- Uroporphyrinogen III
- Coproporphyrinogen III
|
|
late mitochondrial: |
- Protoporphyrinogen IX
- Protoporphyrin IX
|
|
|
Heme degradation
and excretion |
Breakdown of heme |
spleen: |
- Heme → Biliverdin → Bilirubin
|
|
blood: |
|
|
liver: |
|
|
|
Intestine, excretion in feces |
- Stercobilinogen
- Stercobilin
- Urobilinogen
|
|
Kidney, excretion in urine |
|
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
cell/phys (coag, heme, immu, gran), csfs
|
rbmg/mogr/tumr/hist, sysi/epon, btst
|
drug (B1/2/3+5+6), btst, trns
|
|
- Biochemical families
- carbohydrates
- alcohols
- glycoproteins
- glycosides
- lipids
- eicosanoids
- fatty acids / intermediates
- glycerides
- phospholipids
- sphingolipids
- steroids
- nucleic acids
- constituents / intermediates
- proteins
- amino acids / intermediates
- tetrapyrroles / intermediates
|
|
Thyroid hormone metabolic intermediates
|
|
Tyrosine / iodotyrosine |
- Monoiodotyrosine
- Diiodotyrosine
|
|
Thyronine / iodothyronine |
- 3'-Monoiodothyronine
- 3,3'-Diiodothyronine
- 3,3',5-Triiodothyronine (T3)
- 3,3',5'-Triiodothyronine (Reverse T3)
- 3,5,3',5'-Tetraiodothyronine (Thyroxine, T4)
|
|
Thyronamine / iodothyronamine |
- 3-Iodothyronamine
- 3,3',5-Triiodothyronamine
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
noco (d)/cong/tumr, sysi/epon
|
proc, drug (A10/H1/H2/H3/H5)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Worldwide uptake of FRAX.
- Kanis JA1, Johansson H, Oden A, Cooper C, McCloskey EV; Epidemiology and Quality of Life Working Group of IOF.Collaborators (21)Kanis JA, Cooper C, Adachi J, Borgström F, Clark P, Cummings S, Diaz-Curiel M, Dimai HP, Harvey N, Hiligsmann M, Lau E, Lewiecki M, Lips P, Lorenc R, McCloskey E, Ortolani S, Papioannou A, Silverman S, Sosa M, Szulc P, Yoshimura N.
- Archives of osteoporosis.Arch Osteoporos.2014 Dec;9(1):166. doi: 10.1007/s11657-013-0166-8. Epub 2014 Jan 14.
- The worldwide uptake of FRAX is described.INTRODUCTION: The aim of this report was to determine the usage of FRAX worldwide over a 1-year period from 1 May 2012.METHODS: The number of FRAX calculations from each country was assessed over a 1-year period and expressed as calculations per million of t
- PMID 24420978
- Identifying the proton transfer reaction mechanism via a proton-bound dimeric intermediate for esomeprazoles by a kinetic method combined with density functional theory calculations.
- Cao X1, Zhang F, Zhu K, Ye X, Shen L, Chen J, Mo W.Author information 1Research Center of Analysis and Measurement, Zhejiang University of Technology, 18 Chaowang Rd, Hangzhou, Zhejiang, 310014, P.R. China.AbstractRATIONALE: Esomeprazole analogs are a class of important proton pump inhibitors for the treatment of gastro-esophageal reflux diseases. Understanding the fragmentation reaction mechanism of the protonated esomeprazole analogs will facilitate the characterization of their complex metabolic fate in humans. In this paper, the kinetic method and theoretical calculations were applied to evaluate the fragmentation of protonated esomeprazole analogs.
- Rapid communications in mass spectrometry : RCM.Rapid Commun Mass Spectrom.2014 May 15;28(9):1045-50. doi: 10.1002/rcm.6877.
- RATIONALE: Esomeprazole analogs are a class of important proton pump inhibitors for the treatment of gastro-esophageal reflux diseases. Understanding the fragmentation reaction mechanism of the protonated esomeprazole analogs will facilitate the characterization of their complex metabolic fate in hu
- PMID 24677526
- Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids.
- Kihara A.Author information Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo 060-0812, Japan. Electronic address: kihara@pharm.hokudai.ac.jp.AbstractThe sphingolipid metabolite sphingosine 1-phosphate (S1P) is a well-known lipid mediator. As a lipid mediator, S1P must be present in extracellular space and bind to its cell surface receptors (S1P1-5). However, most S1P, synthesized intracellularly, is metabolized without being released into extracellular space, in other words, without functioning as a lipid mediator in the vast majority of cells except those supplying plasma and lymph S1P such as blood cells and endothelial cells. Instead, intracellular S1P plays an important role as an intermediate of the sole sphingolipid-to-glycerophospholipid metabolic pathway. The degradation of S1P by S1P lyase is the first irreversible reaction (committed step) of this pathway. This metabolic pathway is conserved in eukaryotes from yeast to human, indicating its much older origin than the function of S1P as a lipid mediator, which is found to be present only in vertebrates and chordates. The sphingolipid-to-glycerophospholipid metabolism takes place ubiquitously in mammalian tissues, and its defect causes an aberration of several tissue functions as well as abnormal lipid metabolism. Although this metabolic pathway has been known for over four decades, only recently the precise reactions and enzymes involved in this pathway have been revealed. This review will focus on the recent advances in our understanding of the sphingolipid metabolic pathway via S1P and its physiological and pathological roles. This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biology.
- Biochimica et biophysica acta.Biochim Biophys Acta.2014 May;1841(5):766-772. doi: 10.1016/j.bbalip.2013.08.014. Epub 2013 Aug 27.
- The sphingolipid metabolite sphingosine 1-phosphate (S1P) is a well-known lipid mediator. As a lipid mediator, S1P must be present in extracellular space and bind to its cell surface receptors (S1P1-5). However, most S1P, synthesized intracellularly, is metabolized without being released into extrac
- PMID 23994042
Japanese Journal
- Improvement of (R)-1,3-butanediol production by engineered Escherichia coli(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Kataoka Naoya,Vangnai Alisa S.,Tajima Takahisa,Nakashimada Yutaka,Kato Junichi
- Journal of bioscience and bioengineering 115(5), 475-480, 2013-05-00
- … (R)-1,3-Butanediol is a valuable chemical extensively used as a key intermediate for the synthesis of pharmaceuticals and several industrial compounds. …
- NAID 110009611448
- Thermoplastic Polyesters of 2-Pyrone-4,6-Dicarboxylic Acid (PDC) Obtained from a Metabolic Intermediate of Lignin
- Shikinaka Kazuhiro,Hashimoto Yoshiki,Kajita Shinya [他]
- Fiber = 繊維学会誌 : journal of the Society of Fiber Science and Technology, Japan 69(2), 39-47, 2013-02-00
- NAID 40019570217
- 2Gp19 中間代謝物質の同位体比率に基づく代謝フラックス解析法の構築と従来法との比較(代謝工学/脂質工学,一般講演)
Related Pictures
★リンクテーブル★
[★]
- 英
- metabolic intermediate
[★]
- 関
- halfway、intermediary、intermediary body、intermedius、intersex、interstitial、interzonal、middle、moderate
[★]
- 関
- metabolically
[★]